Our results, therefore, constitute a solid rationale for further preclinical investigation of a PCa-TIS targeted, one-two punch approach using inhibitors of the Bcl-2 anti-apoptotic protein family. This evidence concerns the gene BCL2 and posterior cortical atrophy.